Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck : Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany named to The Boston Globe's 'Top Places to Work' List

11/23/2020 | 08:19am EST

Burlington - Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Massachusetts-based businesses, MilliporeSigma, EMD Serono, and EMD Performance Materials, have again been named to The Boston Globe's annual 'Top Places to Work 2020' list.

The award gauges employee sentiments around company strategy and direction, culture, and benefits. Award rankings are based solely on survey responses provided by employees.

'Our Massachusetts-based employees have shown extraordinary focus and perseverance in the fight against Covid-19 as we collaborate with the global scientific community to fight the pandemic,' said Chris Ross, U.S. country speaker for the businesses of Merck KGaA, Darmstadt, Germany and interim CEO of MilliporeSigma. 'Whether serving customers who are developing vaccines and diagnostics, working with the biopharma community to create, improve and prolong life, or enabling the development of next-generation digital devices and technologies, each of our businesses make a positive difference in our region and around the globe.'

This is the second time that all three Massachusetts-based businesses of Merck KGaA, Darmstadt, Germany were recognized in the largest company category.

The Boston Globe annually recognizes more than 100 companies and organizations as the area's leading employers. The three businesses of Merck KGaA, Darmstadt, Germany have a long history and strong community ties in Massachusetts, with some 3,000 employees working across several locations across the state.

Top Places to Work recognizes the best places to work in the state based on internal employee surveys. Employers who enter to be surveyed are placed into one of four groups: small, with 50 to 99 employees; midsize, with 100 to 249 workers; large, with 250 to 999 and largest, with 1,000 or more employees.

About Merck

Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people's lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices the company is everywhere. In 2019, Merck generated sales of EUR16.2 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck's technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science and EMD Performance Materials.

Contact:

Tel: (978) 495 0093

Email: karen.tiano@milliporesigma.com

(C) 2020 Electronic News Publishing, source ENP Newswire

All news about MERCK KGAA
01/26PFIZER : EMD Serono - European Commission Approves BAVENCIO for First-Line Maint..
AQ
01/25MERCK KGAA : DZ Bank gives a Buy rating
MD
01/25PFIZER : Germany's Merck Secure European Commission Approval for Bladder Cancer ..
MT
01/25European Commission Authorizes Use Of Merck-Pfizer Cancer Drug Bavencio
MT
01/22MERCK KGAA : Independant Research sticks Neutral
MD
01/22MERCK KGAA : Barclays reaffirms its Neutral rating
MD
01/21MERCK KGAA : Kepler Cheuvreux remains its Buy rating
MD
01/21MERCK KGAA : Bernstein remains Neutral
MD
01/21MERCK KGAA : JP Morgan maintains a Buy rating
MD
01/21MERCK KGAA : UBS reaffirms its Neutral rating
MD
More news
Financials
Sales 2020 17 362 M 20 989 M 20 989 M
Net income 2020 1 977 M 2 390 M 2 390 M
Net Debt 2020 11 147 M 13 475 M 13 475 M
P/E ratio 2020 30,2x
Yield 2020 1,02%
Capitalization 59 891 M 72 445 M 72 400 M
EV / Sales 2020 4,09x
EV / Sales 2021 3,80x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 139,28 €
Last Close Price 137,75 €
Spread / Highest target 22,7%
Spread / Average Target 1,11%
Spread / Lowest Target -26,7%
EPS Revisions
Managers and Directors
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA-1.85%75 618
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD15.70%27 725
KYOWA KIRIN CO., LTD.3.70%15 327
BETTA PHARMACEUTICALS CO., LTD.32.16%8 638
YUHAN CORPORATION-3.06%4 217
RECIPHARM AB (PUBL)3.92%2 772